Foundation for People-Centric Health Systems, New Delhi. Correspondence to: Dr Chandrakant Lahariya, B-2/173, First Floor, Safdarjung Enclave, New Delhi 110 029, India.
Foundation for People-Centric Health Systems, New Delhi.
Indian Pediatr. 2022 Aug 15;59(8):636-642. doi: 10.1007/s13312-022-2578-2. Epub 2022 Jun 27.
The biggest-ever outbreak of monkeypox disease in non-endemic countries started in May, 2022. Though no monkeypox case has been reported from India, till mid-June, 2022, yet, considering the rate of spread to the non-endemic countries, there is an urgent need of better understanding of the monkeypox virus and disease epidemiology to help clinicians, public health specialists, and policymakers to be prepared for any eventuality. This review summarises the monkeypox disease epidemiology, clinical features, therapies, vaccines and outlines the measures for preparedness and response for a possible outbreak. The disease is known to cause severe outcome in children, pregnant women, and immunocompromised hosts and this group need to be given special attention. The monkeypox disease outbreak (2022) in non-endemic countries should be used as an opportunity by India and other low and middle income countries to strengthen public health surveillance and health system capacity for outbreak and epidemic preparedness and response.
2022 年 5 月，有史以来最大规模的猴痘疫情在非流行国家爆发。尽管截至 2022 年 6 月中旬，印度尚未报告猴痘病例，但考虑到该病毒向非流行国家的传播速度，迫切需要更好地了解猴痘病毒和疾病流行病学，以帮助临床医生、公共卫生专家和政策制定者为任何可能的情况做好准备。本综述总结了猴痘疾病的流行病学、临床特征、治疗方法、疫苗，并概述了为可能的疫情爆发做好准备和应对的措施。该疾病已知会导致儿童、孕妇和免疫功能低下宿主出现严重后果，因此需要特别关注这一群体。印度和其他低收入和中等收入国家应将此次非流行国家的猴痘疫情（2022 年）作为一个机会，加强公共卫生监测和卫生系统的疫情和流行准备及应对能力。
